Endocrinology
=============

- All endocrine emergency, MUST check UPT if productive women. 
- Always find UNDERLYING causes
- Ventilators cannot easily help with hyperventilating patients - problem in RSI

## Pituitary Disorders

### Pituitary Adenoma

- Pituitary adenoma can arise from any type of cell of the anterior pituitary

- Size: < 1cm microadenoma, >1cm macroadenoma

- Function:

  - Hyper-secretion
  - Hypo-function (hypopituitarism) - due to compression of other cell types

- Various types


  | Anterior Pituitary Cell Type  | Clinical Syndrome                                            |
  | ----------------------------- | ------------------------------------------------------------ |
  | Gonadotroph                   | Clinically non-functioning, very rarely causes symptoms due to hormonal hypersecretion |
  | Thyrotroph (TSH-secreting)    | Hyperthyroidism                                              |
  | Corticotroph (ACTH-secreting) | Cushing's disease                                            |
  | Lactotroph (Prolactinoma)     | Hyperprolactinemia                                           |
  | Somatotroph (GH-secreting)    | Acromegaly                                                   |

**Presentation**

Typically present in one or more of the following ways

- With neurological symptoms: visual impairment, diplopia, headache

- Incidental finding on MRI performed for some other reason
- With hormonal abnormalities

**Evaluation of a Pituitary Mass**

- First-line (basal hormonal testing)
  - 8 am cortisol, ACTH
  - FT4 TSH
  - Prolactin
  - Insulin-like growth factor-1 (IGF-1)
  - Testosterone / Estradiol (E2), FSH and LH

- Additional testing for excess production
  - Cushing's disease: dexamethasone suppression test, 24 Hr urine free cortisol
  - Acromegaly: OGTT GH suppression testing
  - TSHoma: TRH stimulation test, octreotide suppression test
- Hormonal deficiency (macroadenoma)
  - Adrenal insufficiency: synthetic ACTH (Synacthen) stimulation test

**Management**

- Of all of the above hormone secreting pituitary adenoma, prolactinoma is the only one that is best treated non-surgically because >95% will respond well to dopamine agonist. This is regardless of the size of the tumour. 

  ![Screenshot 2020-06-23 at 12.50.31](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2012.50.31.png)

- Use surgical resection for

  - **Secretory** adenoma with the exception of prolactinoma (primarily treated with dopamine agonist-carbergoline / bromocriptine)
  - **Compression** on optic chiasm - complete neuro-opthalmologic evaluation
  - **Hypopituitarism** - relative indication: function may not improve

- Hormonal replacement in hypopituitarism

  - Hydrocortisone 15-20 mg/day in 2 - 3 divided doses, commonly:
    - 10 mg on waking up 
    - 5 mg in the afternoon
  - Levothyroxine for hypothyroidism
  - Testosterone / estradiol for hypogonadism

**Management**

- For hormone secreting tumor: Trans-sphenidal surgery is the preferred surgical treatment these days. 

### Acromegaly

-   Clinical feature

    -   Overgrowth of soft tissue

    -   Enlarged jaws, facial features, hands, and feet

-   Diagnosis

    -   Elevated insulin-like growth factor-1

**Most Common Causes**

- Growth hormone-secreting somatotroph adenoma
  - Typically macroadenoma (&geq;1cm)
- Unregulated GH secretion stimulates hepatic secretion of insulin-like growth factor-1 (IGF-1)
  - Causes most of the clinical manifestations of acromegaly

**Presentation:** Intermittent Headache

**Clinical Features**

| Category                | Specific Signs                                               |
| ----------------------- | ------------------------------------------------------------ |
| Local tumour effects    | Headache, VF defects                                         |
| Somatic                 | Enlargement of aural (hands, feet), jaw (prognathism), frontal bones, carpal tunnel syndrome, arthralgia and arthritis. |
| Skin and GI             | Skin tags, oily texture, colon polyps                        |
| Cardiovascular          | LVH, cardiomyopathy, hypertension, CCF                       |
| Pulmonary               | Sleep apnea (central and obstructive)                        |
| Visceromegaly           | Tongue, thyroid gland, liver                                 |
| Endocrine and metabolic | Hypogonadism, insulin resistance, hypertriglyceridemia       |

**Diagnosis**

Biochemical. 

- Screen: Look for elevated IGF-1 concentration
- Results: Inadequate suppression of GH after glucose load (75g - OGTT)
  - GH falls to <1mg/ml within 2 hours in normal subjects
  - Radiological localisation by MRI pituitary

***Case: 27 year old lady, single, no significant PMHx; MRI Brain was done for intermittent headache - sellar-suprasellar mass 3.1 cm, abutting the optic chiasm. Also reports irregular periods x 1 year, increasing finger and feet size.***

Which is the most appropriate test to do next?

- Serum growth hormone releasing hormone (GHRH)
- Serum growth hormone (GH)
- Serum insulin-like growth factor (IGF-1)
- 75-g oral glucose tolerance test for GH suppression

***Answer:*** **Screening with IGF-1 due to suspicion of acromegaly** i..e growth hormone secreting pituitary tumour. This is preferred to direct measurement of GH because IGF-1 has a longer half-life and is a more stable. GH act on liver to secrete IGF-1. GH is hard to measure at random. One may then conduct OGTT for GH suppression for confirmation. 

### Hypopituitarism

- **Pituitary adenoma**
- **Neoplastic**: craniopharyngioma, Rathke's cleft cyst, metastases e.g. breast cancer
- **Post-treatment**: surgery (pituitary), RT (head/neck)
- **Infiltrative / Inflammatory**: autoimmune, hemochromatosis, Langerhans cell histiocytosis
- **Infectious**: TB
- **Vascular**: pituitary tumour apoplexy, Sheehan's syndrome
- **Traumatic**: head injury
- **Drugs**: immunotherapy (checkpoint inhibitors), opiates

**Management**

- Central diabetes insipidus
  - ADH deficiency may occur if posterior pituitary gland / pituitary stalk is involved in the disease process
  - Symptoms: marked polyuria and thirst
  - Treatment: desmopressin (DDAVP - intranasal, oral)



Thyroid disorder
----------------

### Thyroid Exam

![Screenshot 2020-06-23 at 13.03.30](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2013.03.30.png)

![Screenshot 2020-06-23 at 13.04.28](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2013.04.28.png)

![Screenshot 2020-06-23 at 13.05.24](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2013.05.24.png)

![Screenshot 2020-06-23 at 13.05.47](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2013.05.55.png)

![Screenshot 2020-06-23 at 13.06.20](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2013.06.20.png)



### Hypothyroidism

| Category                           | TSH     | FT4     |
| ---------------------------------- | ------- | ------- |
| Primary hypothyroidism             | &uarr;  | &darr;  |
| Subclinical hypothyroidism         | &uarr;  | &lrarr; |
| Secondary (central) hypothyroidism | &lrarr; | &darr;  |

#### Compensated hypothyroidism (organs working)

- 5 - 8x more common in women than in men
- Most common cause of hypothyroidism
  - Chronic autoimmune (Hashimoto's) thyroiditis (>95%)
  - Which is caused by cell- and antibody-mediated destruction of thyroid tissue
- Highly variable clinical manifestations, depending upon the age and duration and severity of TH deficiency

**Clinical Features**

- Fatigue
- Depression
- Cold tolerance
- Hoarseness

| Mechanism                         | Symptoms                                                     | Signs                                                        |
| --------------------------------- | ------------------------------------------------------------ | ------------------------------------------------------------ |
| Slowing of metabolic processes    | Fatigue and weakness, cold intolerance, dyspnea on exertion, weight gain, cognitive dysfunction, constipation | Slow movement and slow speech, delayed relaxation of tendon reflexes, bradycardia |
| Accumulation of matrix substances | Dry skin, hoarseness, edema                                  | Coarse skin, puffy facies and loss of eyebrows, periorbital edema, enlargement of the tongue |
| Other                             | Myalgia and parenthesis, depression, menorrhagia, arthralgia | Diastolic hypertension, pleural and pericardial effusions, ascites |

**Diagnosis**

- Biochemical
- Need to rule out hypothyroidism in patients with statin-induced rhabdomyolysis

#### Decompensated hypothyroidism (organs failing)

- Previously known as mxyedema coma, but this is a misnomer - rarely oedema, rarely coma; better thought of as decompensated hypothyroidism
- Patients with hypothyroidism - under treated / undiagnosed, with no metabolic reserve
- Triggered by physiologic stressors (infections, surgery, trauma, burns, stroke, MI, cold environment etc)
- Typically elderly female

Clinical Features

- Delirium
- Hypothermia
- Bradycardia, shock
- Hypoglycemia

People with hypothyroidism may be pushed into physiologic stress e.g. sepsis, cold exposure, surgery, burns, trauma, medication non-adherence.



![Screenshot 2020-06-23 at 11.41.34](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2011.41.34.png)

**Evaluation of Hypothyroidism**

![Screenshot 2020-06-23 at 11.42.39](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2011.42.39.png)

Central hypothyroidism

- Uncommon
- TSH is inappropriately normal or low
  - Does not increase appropriately as T4 secretion falls
- Either hypothalamic (tertiary hypothyroidism) or pituitary (secondary hypothyroidism)
  - Suspected in the following 

![Screenshot 2020-06-23 at 11.43.35](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2011.43.35.png)

Treatment

- Give synthetic thyroxine (T4, levothyroxine) tablet
  - Deiodinated in peripheral tissues to form T3 (active TH)

![Screenshot 2020-06-23 at 11.44.02](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2011.44.02.png)



**Clinical Features**

- AMS
  - Hypoactive delirium
  - Not typically comatose per se
- Bradycardia
- Hypothermia
- Also might see
  - Features of a precipitating event e.g. stroke
  - Hypoglycemia
  - Hyponatremia
  - Hypoventilation
  - Reduced GI / bladder motility

**Physical Findings**

- Thyroidectomy scar, goiter
- Myxedema
  - Non-pitting oedema of hands/ face/ lower limbs
  - Voice hoarseness, macroglossia, scalloping of the tongue
- Hair loss
- Loss of outer third of eyebrow hair
- Cold intolerance
- Bradycardia, Bradypnea
- Muffled heart sounds
- Pleural effusions
- Abdo distension - secondary to ileus, ascites, ARU

**Investigation**

- TSH / T4 / Cortisol to determine type
  - Extend of reduction in FT4 FT3 does not differentiate between a decompensated state of hypothyroidism, vs compensated. This is also similar to thyrotoxicosis, vs thyroidstorm. 
- Renal panel: for hyponatremia
- FBC, blood cultures, inflammatory markers
  - FBC for leukopenia
  - Blood cultures and inflammatory markers for 
- ECG - bradycardia, prolongation of QTc, small voltage complexes
- Hypoglycemia
- CK for rhabdomyolysis


**Management**

- Aim for normoglycemia
- Correct hyponatremia - will also improve with thyroxine replacement
- Haemodynamic support
  - Fluids
  - Vasopressors - might be refractory to vasopressor treatment, without thyroid hormone replacement and steroids
  - Relief of cardiac tamponade if present - cautiously, these patients are coagulopathic (VWF disfunction)
    - Other invasive procedures need to be done very carefully as well
- Stress dose steroid: **Hydrocortisone 100 mg 8 hourly**
  - Hyperthyroidism can be associated with adrenal insufficiency (as in the converse, where thyroid storms can also be associated with adrenal insufficiency)
- IV levothyroxine replacement, consider T3 replacement(as T4 conversion to T3 can be impaired)
- REFER ENDOCRINE
- Investigate investigate investigate for trigger, consider empirical antibiotics for sepsis (commonest trigger).

### Hyperthyroidism

Symptoms of hyperthyroidism include heat intolerance, frequent bowel movements, increased appetite, diaphoresis, nervousness, restlessness, weight loss, tremor, hair loss, and palpitations, among others. On examination, patients typically present with tachycardia, hypertension, hyperreflexia, and goiter. The patient will have elevated T3, T4, and serum glucose, and TSH may be depressed or elevated depending on the etiology.

#### Thyroid Storm

![Screenshot 2020-06-23 at 11.23.59](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2011.23.59.png)

![Screenshot 2020-06-19 at 10.45.58](figures/Screenshot%202020-06-19%20at%2010.45.58.png)

![Screenshot 2020-06-23 at 11.27.27](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2011.27.27.png)

**Clinical Feature**

- Precipitant: infection is common, need to search and treat it. 

- Hyperthermia typically with diaphoresis (as opposed to dry in heatstroke)

![Screenshot 2020-06-19 at 10.46.46](figures/Screenshot%202020-06-19%20at%2010.46.46.png)

**Diagnosis**

- Primarily clinical diagnosis, BE SUSCIPIOUS
- Consider if 
- Blood test does not differ very much from thyrotoxicosis
- May use Burch Criteria, but note that this is not very specific

![Screenshot 2020-06-23 at 11.28.55](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2011.28.55.png)

![Screenshot 2020-06-23 at 11.29.40](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2011.29.40.png)



**Management**

- Therapies for thyroid storm act by
  - Preventing release of T4 from the thyroid
  - Preventing peripheral conversion of T4 into F3
  - Preventing thyroid hormone synthesis
  - Preventing the sympathetic effects of severely elevated thyroid hormone levels
- As is the case for all endocrinological emergencies, hunt for an underlying cause. Typical triggers: sepsis, surgery, trauma, DKA, MI, CVA, drugs, pregnancy etc. And then treat it
- Corticosteroids
  - Block release of T4 from thyroid, inhibits peripheral conversion
  - Load IV hydrocortisone 200 mg stat, followed by 
- Iodide
  - Works by the wolff-chaikoff effect
    - We would assume that if we take more iodide thyroid make more hormone
    - Wolff-chaikoff effect prevents over production of thyroid hormone, paradoxical suppressive effect of thyroid in the presence of high levels of circulating iodide
  - To be given post-thioamide administration (give it an hour first)
  - Otherwise, the initial dosing might precipitate an increase in thyroid hormone synthesis before the WC effect takes hold
  - Lugol's solution, KI solution, 5 drops Q6 hourly
  - For allergies to iodine, use lithium instead

![Screenshot 2020-06-19 at 10.49.25](figures/Screenshot%202020-06-19%20at%2010.49.25.png)

![Screenshot 2020-06-19 at 10.50.41](figures/Screenshot%202020-06-19%20at%2010.50.41.png)

**Management**

- **Supportive therapy**
  - Treat hyperthermia (avoid NSAIDs/salicylates - protein bound, can increase free thyroid hormone levels)
  - Replace volume with strict IO charting
  - Vasopressors
  - Inotropes if the BP is low
  - For rapid AF, rapid ventricular rates, can consider magnesium sulphate

![Screenshot 2020-06-19 at 10.56.21](figures/Screenshot%202020-06-19%20at%2010.56.21.png)

- If people can tolerate, go for propranolol. 
- Np, he is staying that the peripheral effect of non selective beta blocker is not ideal (why). Many patients cannot tolerate it. Therefore we would think about the selective beta blockers. However, if we think that the patients can tolerate the peripheral effects of non beta blocker, it is good to go for propranolol so that we can also take advantage of its T4 conversion blocking power.

- **Search for Etiology**
  - Complete septic work-up
- Acute manamgenet
  - Block synthesis: thionamides - PTU 200 mg 4 -6 hourly
  - Block release: PO Lugol's iodine / IV sodium iodide - start 1 hour after PTU
  - ![Screenshot 2020-06-23 at 11.32.33](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2011.32.33.png)
  - 

#### Thionamide induced agranulocytosis

Always a risk if patient is started on carbimazole or propyluracil. Whenever these patients have fever or signs of infection for these patients, do FBC asap

![Screenshot 2020-06-23 at 11.19.37](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2011.19.37.png)

- Admit, work up for sems

![Screenshot 2020-06-23 at 11.21.01](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2011.21.01.png)

**Acute management**

- Work up for sepsis, empirical broad spectrum antibiotics
- Identification and immediate discontinuation of causative agent
- Consider G-CSF
  - Reduce time to haematological recovery

![Screenshot 2020-06-23 at 11.22.15](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2011.22.15.png)

- 1:10000 risk of ruminant liver disease for PTU; need to counsel patient; special cases when we would use PTU over carbamizole: thyroid storm, pregnancy







### Sick Euthyroid

### Thyroiditis

#### Subacute Thyroiditis

- Unusual for Graves disease thyroid to be tender. If tender, think of this

Clinical Feature

- Neck pain / discomfort, tender diffuse goitre
- Presumed: viral infection or post viral inflammatory process
- Not a/w thyroid autoimmunity

Prognosis

- Self-limiting 'triphasic' course, monitor for recovery

Symptomatic management

- Pain control: NSAIDs e.g. ibuprofen; or corticosteroids
- Heart rate control: beta-blocker

![Screenshot 2020-06-23 at 11.14.25](/Users/jzan/Library/Application%20Support/typora-user-images/Screenshot%202020-06-23%20at%2011.14.25.png)



#### 

### Thyroid Cancer

## Disorders of Calcium Metabolism

### Hypercalcaemia

![Screenshot 2020-06-23 at 11.48.21](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2011.48.21.png)

![Screenshot 2020-06-23 at 11.48.59](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2011.48.59.png)

Answer: serum parathyroid hormone (PTH)

#### Clinical

![Screenshot 2020-06-23 at 11.51.13](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2011.51.13.png)



#### W/U approach

![Screenshot 2020-06-23 at 11.49.59](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2011.49.59.png)

- Outpatient hypercalcaemia is often primary; inpatient hypercalcemia if often secondary to malignant cause

#### Acute Management

| Treatment | Mode of Action | Onset of action | Duration of action |
| --------- | -------------- | --------------- | ------------------ |
|           |                |                 |                    |



![Screenshot 2020-06-23 at 11.51.59](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2011.51.59.png)

- Cannot use calcitonin for more than a few days because of the side effect of tachyphylaxis



### Primary Hyperparathyroidism

- PTH-mediated 
- End-organ complications: renal calculi, osteoporosis

![Screenshot 2020-06-23 at 11.53.45](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2011.53.45.png)

Note that benign familial hypocalciuric hypercalcaemia does not require treatmnet

![Screenshot 2020-06-23 at 11.56.07](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2011.56.07.png)

### Malignancy-related Hypercalcaemia

![Screenshot 2020-06-23 at 11.57.17](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2011.57.17.png)



### Hypocalcemia

![Screenshot 2020-06-23 at 11.58.43](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2011.58.43.png)



#### Hypoparathyroidism

![Screenshot 2020-06-23 at 11.59.52](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2011.59.52.png)

**Treatment**

![Screenshot 2020-06-23 at 12.01.00](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2012.01.00.png)

- Patient will be on vitamin B long term. 



### Osteoporosis

![Screenshot 2020-06-23 at 12.53.11](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2012.53.11.png)

![Screenshot 2020-06-23 at 12.53.31](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2012.53.31.png)

![Screenshot 2020-06-23 at 12.54.03](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2012.54.03.png)

![Screenshot 2020-06-23 at 12.54.58](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2012.54.58.png)

![Screenshot 2020-06-23 at 12.55.24](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2012.55.24.png)

![Screenshot 2020-06-23 at 12.56.34](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2012.56.34.png)

![Screenshot 2020-06-23 at 12.56.46](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2012.56.46.png)

- VElosafine? Venous thrombosis, better for younger patients
- Supplement 500 mg/day elemental calcium to avoid the kidney stones

Sugar Control Related Disorders
-------------------------

### Diabetes

Special interest: technology in management of diabetes in children - Dr Suresh Rama Chandran.

#### Overview

What is diabetes mellitus

- A complex metabolic disorder
- Characterized by a 

![Screenshot 2020-06-24 at 11.11.34](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2011.11.34.png)

![Screenshot 2020-06-24 at 11.12.03](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2011.12.03.png)

![Screenshot 2020-06-24 at 11.12.40](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2011.12.40.png)



Monogenic Diabetes - a single gene is causing the diabetics; Unlike Type II which is polygenic and multi-factorial.

LADA progression to insulin deficiency is slower, and remain insulin dependent for a while.

Peripheral neuropathy - severity indicates damage; initial phase more positive symptoms; 



#### Type II DM Pathogenesis

![Screenshot 2020-06-24 at 11.15.59](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2011.15.59.png)

![Screenshot 2020-06-24 at 11.20.15](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2011.20.15.png)

![Screenshot 2020-06-24 at 11.21.29](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2011.21.29.png)

![Screenshot 2020-06-24 at 11.22.08](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2011.22.08.png)





#### Diagnosis

![Screenshot 2020-06-24 at 11.23.15](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2011.23.15.png)



![Screenshot 2020-06-24 at 11.26.02](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2011.26.02.png)



![Screenshot 2020-06-24 at 11.26.12](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2011.26.12.png)

![Screenshot 2020-06-24 at 11.27.34](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2011.27.34.png)

Diabetic Neuropathy

- Divide the hypoglycaemic symptoms into autonomic vs somatic symtoms; 

![Screenshot 2020-06-24 at 11.29.44](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2011.29.44.png)



- Wet risk fungal foot; dry risk bad ulcers

![Screenshot 2020-06-24 at 11.32.23](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2011.32.23.png)



![Screenshot 2020-06-24 at 11.33.53](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2011.33.53.png)

![Screenshot 2020-06-24 at 11.34.36](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2011.34.36.png)



![Screenshot 2020-06-24 at 11.35.33](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2011.35.33.png)



![Screenshot 2020-06-24 at 11.37.35](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2011.37.35.png)

![Screenshot 2020-06-24 at 11.38.18](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2011.38.18.png)

![Screenshot 2020-06-24 at 11.40.04](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2011.40.04.png)

![Screenshot 2020-06-24 at 11.41.48](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2011.41.48.png)

![Screenshot 2020-06-24 at 11.42.03](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2011.42.03.png)

![Screenshot 2020-06-24 at 11.43.09](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2011.43.09.png)



Legacy effect - complications are likely to progress for a few years even if the blood sugar remains in control.



#### Health Impact

The majority of deaths from diabetes also results primarily from the increase in cardiovascular disease and chronic renal failure. Diabetics have twice the mortality of non-diabetics. The risk of cardiovascular disease in diabetics is so high that it is assumed that they have cardiovascular disease if they have diabetes.

#### Medications for Diabetes Patient

| Feature       | Metformin            | Sulfonylurea                 | Thiazolidinedione                      | Meglitinide                                    | DPP-4 Inhibitor                              | SGLT2 Inhibitor                                              | GLP-1 Agonist                | Insulin          |
| ------------- | -------------------- | ---------------------------- | -------------------------------------- | ---------------------------------------------- | -------------------------------------------- | ------------------------------------------------------------ | ---------------------------- | ---------------- |
| Mechanism     | Activates AMP-Kinase | Stimulates insulin secretion | Activates nuclear transcription factor | Like thiazoilidinedion e but more short acting | Inhibits DPP-4, increases incretin secretion | Inhibits SGLT2 in the kidney & Activates GLP-1 receptors, mimics incretin | Overcomes insulin resistance |                  |
| Examples      | Metformin            | Glipizide, glimeperide       | Pioglitazone, rosiglitazone            |                                                | Sitigliptin, saxagliptin                     | Canagliflozin, empagliflozin                                 | Exenatide, liraglutide       | Glargine, lispro |
| A1C Reduction | 1% to 2%             | 1% to 2%                     | 1% to 2%                               |                                                | 0.5% to 1%                                   | 0.5% to 1%                                                   | 1% to 2%                     | \>2%             |
| Weight Effect | Neutral or reduction | Gain & Gain                  | Neutral                                |                                                | Reduction                                    | Reduction                                                    | Gain                         |                  |
|               |                      |                              |                                        |                                                |                                              |                                                              |                              |                  |

Bile acid sequesters 

Side Effects | GI; Lactic acidosis | Hypoglycemia & Heart failure; edema & Rare & GU symptoms, dehydration & GI, pancreatitis, medullary thyroid cancer& Hypoglycemia\
Evidence of CVD reduction & Yes & No & Yes & No & Yes & Yes & No\
Costs & Low & Low & Low & High & High & High & Intermediate\

Several guidelines recommend treatment to reduce HbA1c levels to less than 7%; however, clinical trials have not demonstrated reductions in cardiovascular events or mortality with intensive glucose control. Recently (March 2018), the American College of Physicians recommended that the treatment goal in patients with Diabetes should be an HbA1c between 7% and 8%; this is due to findings showing that treatment to targets of 7% or less compared to targets of 8% did not reduce deaths or macrovascular complications such as heart attack or stroke, but did result in substantial harms. Studies have also shown inconsistent improvement with intensive glucose control in microvascular complications, including nephropathy, but increased adverse effects, including weight gain, fluid retention, and symptomatic hypoglycemia.

- Max metformin is 2000 mg/day

![Screenshot 2020-06-24 at 11.55.07](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2011.55.07.png)

- Extreme lactic acidosis on metformin is very rare; 

![Screenshot 2020-06-24 at 11.58.32](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2011.58.32.png)

![Screenshot 2020-06-24 at 11.57.36](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2011.57.36.png)

- Useful in reducing stroke in someone with previous stroke



![Screenshot 2020-06-24 at 11.59.42](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2011.59.42.png)

![Screenshot 2020-06-24 at 12.00.39](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2012.00.39.png)

![Screenshot 2020-06-24 at 12.01.08](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2012.01.08.png)





![Screenshot 2020-06-24 at 12.02.56](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2012.02.56.png)

- Linagliptin does not need dose readjustment in renal patients.

![Screenshot 2020-06-24 at 12.03.40](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2012.03.40.png)



- More calories loss;
- 2- 3 kg in 2- 3 months

![Screenshot 2020-06-24 at 12.05.47](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2012.05.47.png)

- SGLT2 inhibitor patient with DKA may have normlflcose;

- Increased risk of ketosis; especially insulin deficient.
- EMPA-REG trial: reduction in death from heart failure with EMPA
  - This seems to be a class effect
  - Mechanism is unclear

![Screenshot 2020-06-24 at 12.13.44](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2012.13.44.png)

- With heart event and risk factors, move towards GLP-1 RAs

   ![Screenshot 2020-06-24 at 12.15.45](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2012.15.45.png)

![Screenshot 2020-06-24 at 12.16.16](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2012.16.16.png)'![Screenshot 2020-06-24 at 12.18.42](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2012.18.42.png)

![Screenshot 2020-06-24 at 12.18.55](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2012.18.55.png)



![Screenshot 2020-06-24 at 12.21.46](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2012.21.46.png)

![Screenshot 2020-06-24 at 12.23.05](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2012.23.05.png)

#### Insulin

Basal insulin is not suitable when:

- Low fasting glucose (<8 mmol/L)
- Hba1c > 10%
- Unwilling to titrate insulin

Basal is the DC, we may also consider the AC adjustment. 

How to titrate the basal insulin

| Capillary Blood Glucose (mammal/L) | Dose Adjustment |
| ---------------------------------- | --------------- |
| <4.0                               | -2              |
| 4 - 7                              | No change       |
| 7.1 - 10                           | +2              |
| >10                                | +4              |

Adjust every 3 days based on pre-breakfast reading. 

When to intensify therapy / introduce prandial insulin

- When basal insulin reaches 0.5 to 0.6 units/kg
- When nocturnal hypoglycaemia develops with further increase in basal insulin
- When HbA1c nears target adding a basal insulin will have a high impact; 8 - 8.5

Intensification of insulin regimen

- Options to intensify insulin beyond basal
  - Add a dose of prandial insulin
  - Change to premixed insulin 2x /day
  - Start 

![Screenshot 2020-06-24 at 12.51.36](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2012.51.36.png)

- Stop the drugs that stop the endogenous injection
- Rotating the site is important to prevent 
- 0.8 - 1.5 u/kg is the range of insulin requirement; may need 0.5 as basal and the half as bolus



Sliding scale is used in SC or IV

- IV is used in extreme hyperglycaemia - every hour and adjust
- SC insulin needs to be given before the raise in glucose;
  - No idea as to what the insulin requirement is
  - Check glucose pre-meal;

![Screenshot 2020-06-24 at 13.04.10](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2013.04.10.png)



![Screenshot 2020-06-24 at 13.07.39](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2013.07.39.png)

#### Diabetic Ketoacidosis

Diagnosis: HCO3 < 18, elevated serum or urine ketones, Glucose >14 with **acidosis**

- Acidosis NOT acidemia is required; may have normal pH

- **Ketone** we measure is beta-hydroxybutyric acid would be the most accurate test

  

![Screenshot 2020-06-19 at 10.07.24](figures/Screenshot%202020-06-19%20at%2010.07.24.png)

![Screenshot 2020-06-19 at 10.07.34](figures/Screenshot%202020-06-19%20at%2010.07.34.png)

**Management**

- ![Screenshot 2020-06-24 at 13.01.51](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-24%20at%2013.01.51.png)
- Fluid is super important
- Insulin therapy
  - **Hourly capillary glucose monitoring** and **potassium** levels
    - In insulin therapy, worry hypokalemia because insulin increases the permeability of cells to potassium (also Mg and Phosphate)
    - Start potassium replacement around 5 mmol/L; start at **20 mmol/hr KCl** replacement
      - IV insulin or calcium gluconate may be used if there is EKG changes for cardioprotective effect
      - Do not wait until hypokalemia
      - If patient is already hypokalemic, stop insulin, correct hypokalemia, then restart insulin
  - In severe acidosis, the requirement is higher than textbook recommendations due to increased insulin resistance
  - Consider IV insulin bolus 10 u if infusion set-up is taking too long
  - Consider IV insulin bolus in severe acidosis
  - IV insulin dosage **0.1 u/kg/hr**, can consider higher dosages in severe acidosis (severe acidosis results in insulin resistance, patients with chronic high dose insulin requirements might also require larger insulin infusion dosages of up to 0.3 unit/kg/hr)
  - Start patients on long acting basal insulin regimen as soon as possible (resume patient's old insulin home dosages if known) e.g. for insulin naive patients, Lantus starting is 0.25 unit/kg/day split into BD dose.
- Acidosis correction
  - Acidosis should rapidly correct with IV fluid replacement and insulin therapy
  - In severe acidosis <6.9, consider increasing insulin dosage
  - Avoid sodium carbonate which may worsen acidosis but improve pH
    - pH is the measure of extra cellular acid
    - Extracellular pH created
    - In patients with high circulating H+ form H2CO3 -> CO2, and H2O-
    - These patients have kussmaul breathing and have max respiratory drive, cannot blow off the CO2, eventually these then becomes H+ and Hco3-, producing more acid
    - Thus main stay therapy is fluid and insulin, if we HAVE to give, give little and slow.
  - Avoid intubation if you can
    - These are high risk intubations and is important to optimise patient's haemodynamic parameters as much as possible if intubation cannot be avoided
    - Obliterate the respiratory drive
      - Ventilator cannot match such respiratory drive to hyperventilate patients
      - CO2 will go up, worsen acidosis
    - Induce profound drop in pressure
    - If have to do it, say for a optimise the haemodynamics as much as possible before RSI
      - Make sure the patient has boluses of fluid
      - If HoTN, keep blood pressure up with vasopressor
  - End point of insulin therapy is the correction of HAGMA (the ketoacidosis)
    - Therefore, glucose levels might correct before the HAGMA does. So while insulin therapy is still on, start the patients on glucose infusions to avoid hypoglycaemia with insulin therapy. Consider starting IV dextrose infusions once capillary glucose readings are around 14 mmol/L
- Monitoring for response to therapy and complications
  - NAGMA
  - Fluid overload
    - Pediatrics DKA often half the fluid dose
  - Hypokalemia and hypoglycaemia - from IV insulin  
  - Cerebral oedema - patients with more hyperosmolar state, bring to a place with resus and more monitoring capability.
    - Young patient, paediatric patients at risk
    - Patients with significant hyperosmolarity, calculated serum ism >330
    - Can be seen in 
    - ![Screenshot 2020-06-19 at 10.37.07](figures/Screenshot%202020-06-19%20at%2010.37.07.png)
  - Consider DVT prophylaxis

![Screenshot 2020-06-19 at 10.38.53](figures/Screenshot%202020-06-19%20at%2010.38.53.png)

- Anuric - not as volume depleted, and not losing as much potassium; Go a lot more slower and more gently; Insulin is really excreted, go lower on the dose; Instead of 10 unit IV dose, we use 6 - 8 unit in renal patients - half life is prolonged and glucose and K can drop a lot faster. 

  

- ![Screenshot 2020-06-19 at 10.37.49](figures/Screenshot%202020-06-19%20at%2010.37.49.png)

#### Hyperosmolar Hyperglycemic State



**Management**

- Correct fluid deficit slowly over days aiming for euvolemia
  - Combination of osmotic diuresis
  - GI loss and reduced appetite
  - Use balanced crystal if large volume
- Insulin therapy

### Hypoglycemia

**Causes**

- Drugs
  - Insulin: accidental, iatrogenic, factitious/self harm
  - Increased insulin secretion: e.g. sulfonylureas
  - Other diabetic medications: SGLT2 inhibitors, metformin
  - Salicylate poisoning
  - NSAIDs
  - Non-selective beta-blockers
- Disease
  - Myxedema coma
  - Adrenal insufficiency
  - Hepatic failure
  - Renal failure (pre-disposition with insulin dose)
  - Increased endogenous insulin secretion (insulinoma)
- Depletion
  - Exercise
  - Starvation states
  - Alcohol binges

**Investigation**

- Serum insulin, c-peptide, cortisol

**Management**

- Try to replenish glucose: if obtunded IV dex, if conscious, give yummy sugary foods orally
  - Dessert is a great source of sugar replenishment
    - 1x premium, delicious velvety smooth ice cream from Creamier = 6L of 5% dextrose - patient satisfaction goes up, no risk of fluid overload
    - 1x snickers bar = 1.25 L of 5% dextrose
  - **IV dextrose** bolus: 50%, 20%, 10%, 5%
    - 40 ml bolus for D50 typically, and follow with large flush **20 mls**
    - If need to keep for a long time, try to use D5 over D10 because less irritating to the veins
      - Fast supplement over 2 hours (If D10 try to run ASAP)
      - For slow supplement give over 4 - 6 hours
- If persistent hypoglycaemia
  - Try to replenish again
  - Consider exogenous **corticosteroids** to increase insulin resistance and induce gluconeogenesis
  - Consider **octreotide** -  a somatostatin analogue for hypoglycaemia secondary to sulfonylurea toxicity (acts by inhibiting endogenous insulin release)
  - Look for other causes

### Insulinoma

A pancreatic tumor that secretes insulin and is associated with episodes of hypoglycemia and resultant cognitive dysfunction, palpitations, diaphoresis, and tremor.

Adrenal
-------

- Thyroid storm and some other endocrine conditions may cause adrenal problems
- CAH treatment is corticosteroids
- Neonatal shock is uncommon, CAH is one of the important reasons to get
  - Check out the metabolic derangements in CAH!
  - Never forget neonatal trauma

![Screenshot 2020-06-19 at 11.02.19](figures/Screenshot%202020-06-19%20at%2011.02.19.png)![Screenshot 2020-06-19 at 11.07.42](figures/Screenshot%202020-06-19%20at%2011.07.42.png)

![Screenshot 2020-06-19 at 11.12.31](figures/Screenshot%202020-06-19%20at%2011.12.31.png)

- Number 1 cause of chronic adrenal insufficiency
  - Withdrawal from steroids
  - Addison's disease: Patch pigmentation of the oral mucosa, 
    - Patients are often diagnosed early in life, 

- DIVC patients esp meninggococcemia - adrenal hemorrhage - waterhouse-friedrichson syndrome
- Check point inhibitors have profound and bizarre complications
  - BE WORRIED! Immunotherapy comes in for vague symptoms e.g. SOB CP CF 
- IV hydrocortisone and IV dexamethasone take 1 - 2 hours to work; in the meantime support with fluids and vasopressors. 



### Carcinoid Syndrome

-   Clinical features

    -   Presents with intermittent diarrhea and skin flushing

    -   a/w intestinal neuroendocrine tumors, pulmonary and/or tricuspid valve disease

### Pheochromocytoma

![Screenshot 2020-06-23 at 12.30.08](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2012.30.08.png)

![Screenshot 2020-06-23 at 12.30.41](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2012.30.41.png)



A tumor that arises from neuroendocrine cells in adrenal medulla. About 25% is inherited

-   VHL gene - von Hippel-Lindau

-   RET gene - multiple endocrine neoplasia type 2

-   NF1 gene - neurofibromatosis

Symptoms result from increased catecholamine secretion

-   Clinical features: episodic

    -   Headache

    -   Tachycardia / palpitations

    -   Sweating

    -   Hypertension

    -   May be accompanied by panic attacks

-   W/P - Rule of 10s

    -   10% bilateral

    -   10% extraadrenal (***paragangliomas***)

    -   10% malignant

    -   10% familial

-   Diagnosis

    -   Drug resistant HTN

    -   Hyperglycemia

    -   Elevated urinary and plasma catecholamines and metanephrines
    
        -   24 hr fractionated metanephrines
        -   Or plasma
    
        ![Screenshot 2020-06-23 at 12.32.43](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2012.32.43.png)

Symptoms of pheochromocytoma include headache, diaphoresis, palpitations, tremor, nausea, weakness, anxiety, nervousness, irritability, and weight loss, among other symptoms. On physical examination, patients typically present with tachycardia and severely elevated blood pressure. For laboratory studies, the patient will have elevated urinary VMA, urinary HVA, urinary metanephrines, and serum glucose. Pheochromocytoma may be associated with various syndromes, such as multiple endocrine neoplasia and Von Hippel-Lindau disease.

Differentiate from neuroblastoma in children.

![Screenshot 2020-06-23 at 12.33.29](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2012.33.29.png)



Managemnent

- Work up location

- ![Screenshot 2020-06-23 at 12.34.58](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2012.34.58.png)

- CCB can be added if insufficient alpha blockage

- ![Screenshot 2020-06-23 at 12.35.55](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2012.35.55.png)

- &beta;-blocker can be used to control heart rate (reflex tachycardia from &alpha;-blockage)

  - Note, do NOT start &beta;-blocker until adequate 
  - Mark of adequate alpha blockage: BP < 130/80 

  

### Cushing Syndrome

Differentiate Cushing's syndrome from simple obesity:

1. Central adiposity
2. Supraclavicular fat pad
3. Uncontrolled hyperglycemia
4. Ecchymoses

![Screenshot 2020-06-23 at 12.16.37](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2012.16.37.png)

-   Clinical manifestations

    -   Central obesity

    -   Skin atrophy and wide purplish striae

    -   Proximal muscle weakness

    -   HTN

    -   Glucose intolerance

    -   Skin hyperpigmentation (if due to ACTH excess)

    -   Depression and anxiety

-   Diagnosis

    -   24-hour urinary cortisol excretion
-   Late night salivary cortisol assay
    -   Low-dose dexamethasone suppression test
-   ![Screenshot 2020-06-23 at 12.17.23](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2012.17.23.png)

![Screenshot 2020-06-23 at 12.19.40](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2012.19.40.png)

![Screenshot 2020-06-23 at 12.20.46](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2012.20.46.png)

ACTH independent Cushing's. 



Establishing the causes of CS (Localization)

![Screenshot 2020-06-23 at 12.22.45](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2012.22.45.png)



Complications of Cushing's Syndrome

![Screenshot 2020-06-23 at 12.24.16](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2012.24.16.png)



#### Overnight Dexamethasone Suppression Test
Dexamethasone suppression test is used to evaluate hypercortisolism (i.e. Cushing Syndrome); suggestive manifestations include proximal muscle weaknss, facial plethora, and supravlavicular fat pads. Hypercortisolism is occasionally seen in MEN1, generally due to ACTH secreting pituitary tumors or adrenal tumors. Primary hyperparathyroidism is also seen in MEN1 and MEN2A. 

#### Primary Aldosteronism 

![Screenshot 2020-06-23 at 12.25.28](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2012.25.28.png)

![Screenshot 2020-06-23 at 12.26.08](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2012.26.08.png)

![Screenshot 2020-06-23 at 12.27.24](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2012.27.24.png)

![Screenshot 2020-06-23 at 12.28.12](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2012.28.12.png)





### Addison's Disease



### Addisonian Crisis

### Adrenal Insufficiency

![Screenshot 2020-06-23 at 12.03.19](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2012.03.19.png)

What investigation?

- ACTH (synacthen) stimulation test

Low blood pressure and low sodium suggest adrenal insufficiency.

Worry exogenous glucosterid therapy which the patient may have stopped taking. Precipitating the crisis.

![Screenshot 2020-06-23 at 12.04.53](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2012.04.53.png)

![Screenshot 2020-06-23 at 12.06.18](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2012.06.18.png)

![Screenshot 2020-06-23 at 12.07.47](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2012.07.47.png)

![Screenshot 2020-06-23 at 12.09.30](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2012.09.30.png)



Glucocorticoid replacement uses a short acting glucocorticoid such as 

![Screenshot 2020-06-23 at 12.11.23](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2012.11.23.png)

Missing slides....



### Addison's Disease

![Screenshot 2020-06-23 at 12.13.23](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2012.13.23.png)

![Screenshot 2020-06-23 at 12.13.43](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2012.13.43.png)

- Primary people have both mineral corticoid and glucocorticoid deficiency

![Screenshot 2020-06-23 at 12.14.26](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2012.14.26.png)





## Metabolic Syndrome

### Dyslipidemia



## Case Based Discussion

By Swee Du Soon

### Hyperthyroidism

| Condition               | TSH     | Free T4 |
| ----------------------- | ------- | ------- |
| Primary hyperthyroidism | &darr;  | &uarr;  |
| Central hyperthyroidism | &lrarr; |         |

Common causes of hyperthyroidism in the wards

![Screenshot 2020-06-23 at 11.10.56](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2011.10.56.png)

1. TSH-secreting pituitary adenoma
2. Factitious hyperthyroidism
3. Subacute thyroiditis
4. Graves' disease
5. ![Screenshot 2020-06-23 at 11.13.30](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2011.13.30.png)

![Screenshot 2020-06-23 at 11.11.42](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2011.11.42.png)

 Here are the most useful studies to do

1. TSH receptor antibody (TRAb) status is helpful

   - Elevated in Graves disease or autoimmune hyperthyroidism
   - Non-ev

   c. No uptake - acute thyroidistis

   d. Hyperfunctioning thyroid



#### 

![Screenshot 2020-06-23 at 11.16.45](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2011.16.45.png)

Which of the following investigation would be the most helpful?

- Full blood count (FBC)
- C reactive protein (CRP)
- Erythrocyte sedimentation rate (ESR)
- Interleukin-6

FBC for white blood cells, worry agranulocytosis secondary to carbimazole use. 

![Screenshot 2020-06-23 at 11.19.11](/Users/jzan/Dropbox/00-medicine/mkdoc-md-notes/docs/figures/Screenshot%202020-06-23%20at%2011.19.11.png)



